Dysbetalipoproteinemia: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) |
Usama Talib (talk | contribs) |
||
| Line 16: | Line 16: | ||
* Intermittent claudication | * Intermittent claudication | ||
* Gangrene of the lower extremities | * Gangrene of the lower extremities | ||
==Prognosis== | |||
*Patients with dysbetalipoproteinemia have an increased risk for coronary artery disease and peripheral vascular disease. | |||
*With treatment, most people show a significant reduction in lipid levels. | |||
=Diagnosis= | =Diagnosis= | ||
Revision as of 16:59, 9 November 2016
Overview
Classification
Historical perspective
Pathophysiology
Causes
Differential Diagnoses
Epidemiology and Demographics
Screening
Natural History, Complication, Prognosis
Complications
- Heart attack
- Stroke
- Peripheral vascular disease
- Intermittent claudication
- Gangrene of the lower extremities
Prognosis
- Patients with dysbetalipoproteinemia have an increased risk for coronary artery disease and peripheral vascular disease.
- With treatment, most people show a significant reduction in lipid levels.
Diagnosis
History and Symptoms
Physical Exam
Laboratory Findings
Molecular Genetic Testing
Treatment
Prevention
- Screening the family members of those with familial dysbetalipoproteinemia may lead to early detection and treatment.
- Early treatment and avoiding other risk factors for vascular disease (such as smoking) are crucial to preventing early heart attacks, strokes, and blocked blood vessels.